Two Sigma Advisers, LP’s Vertex Pharmaceuticals Inc Position
Does Two Sigma Advisers, LP own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 98.4K shares worth $45M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$45M
Q4 2025
Shares
98.4K
% of Portfolio
+0.09%
Quarters Held
27
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 98.4K | $45M | +0.09% |
| Q3 2025 | 11.5K | $5M | +0.01% |
| Q2 2025 | 900 | $400,680 | 0.00% |
| Q4 2024 | 3.2K | $1M | 0.00% |
| Q3 2024 | 29.4K | $14M | +0.03% |
| Q2 2024 | 171.8K | $81M | +0.18% |
| Q1 2024 | 122.0K | $51M | +0.12% |
| Q4 2023 | 87.5K | $36M | +0.08% |
| Q3 2023 | 143.4K | $50M | +0.13% |
| Q2 2023 | 214.4K | $75M | +0.19% |
| Q1 2023 | 60.4K | $19M | +0.05% |
| Q4 2022 | 17.8K | $5M | +0.01% |
| Q3 2022 | 23.0K | $7M | +0.02% |
| Q2 2022 | 24.7K | $7M | +0.02% |
| Q1 2022 | 17.8K | $5M | +0.01% |
| Q4 2021 | 12.3K | $3M | +0.01% |
| Q3 2021 | 782.7K | $142M | +0.37% |
| Q2 2021 | 1.0K | $202,000 | 0.00% |
| Q4 2020 | 262.8K | $62M | +0.17% |
| Q3 2020 | 777.6K | $212M | +0.60% |
| Q2 2020 | 1.22M | $353M | +1.02% |
| Q1 2020 | 1.10M | $262M | +1.00% |
| Q4 2019 | 1.20M | $264M | +0.61% |
| Q3 2019 | 903.6K | $153M | +0.37% |
| Q2 2019 | 935.7K | $172M | +0.43% |
| Q1 2019 | 1.00M | $185M | +0.47% |
| Q4 2018 | 745.0K | $123M | +0.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of VRTX.